Immune Response: Investigating the role of vitamin D in asthma
Vitamin D deficiency has burgeoned into a major public health concern, exacerbated by dietary habits and pollution among other factors (Cui et al., 2023). While vitamin D is well known to be important for maintaining healthy bones, it has also been linked with various immune disorders, including asthma.
Supplements of vitamin D are being increasingly used to treat immune-related conditions. However, it remains unclear precisely how vitamin D is able to improve the outcome of these disorders (Scragg, 2018). Now, in eLife, Scott Weiss, Ardu Halu and co-workers – including Ayşe Kiliç as joint first author with Halu – report how vitamin D regulates an immune response that is a major contributor to asthma (Kiliç et al., 2023).
First, the team – who are based at Brigham and Women’s Hospital and Harvard Medical School, and institutes in Germany, Japan, Russia, and the United States – revisited the findings of a clinical trial called the Vitamin D Antenatal Asthma Reduction Trial (VDAART). In the trial, pregnant women who had a history of Asthma or allergies (or whose partner, the other biological parent, had a similar history), were given low or high doses of vitamin D during pregnancy. Analyses of the data found that higher vitamin D supplementation did not significantly reduce asthma in the offspring (Litonjua et al., 2016; Litonjua et al., 2020). However, a more nuanced reanalysis – which adjusted for baseline vitamin D levels to account for factors such as dietary intake – reported a reduced risk of asthma in the offspring of women who received a higher dose of vitamin D during pregnancy (Wolsk et al., 2017).
Kiliç et al. set out to find the genetic underpinnings of this protective effect, focusing their attention on chromosome 17, which contains regions strongly associated with asthma and other immune diseases (Bansal et al., 2021). Across chromosome 17 are sites where the receptor for vitamin D (known as VDR) can bind. Bioinformatic analysis revealed that some of these VDR binding sites overlapped with genetic variants associated with diseases triggered by the immune response mediated by T helper type 2 cells. These immune cells (known as Th2 for short) are a subset of white blood cells which respond proactively to invading pathogens like helminths, as well as recurrent exposures. Th2 cells act by producing inflammatory mediators as well as by modulating the activity of other cells in the immune system. They are also activated by allergens, such as mites and pollens, which can lead to allergic inflammation and disorders like asthma.
A detailed exploration of these overlapping regions suggested that VDR can trigger a cascade that regulates genes involved in the Th2 immune response. This genetic regulation could either promote or repress the Th2 response, depending on other genetic variants present in the proximity.
With a hypothesis established, the researchers tested their findings in mice which had been exposed to extracts from house dust mites to mimic the asthma phenotype (Figure 1A). They found that mice deficient in vitamin D or lacking VDRs displayed a more severe phenotype. Further experiments revealed that house dust mite exposure also caused the Th2 cells to express higher levels of VDR. When these Th2 cells were exposed to calcitriol (the active form of vitamin D), the VDRs bound to the calcitriol and migrated from the cytosol into the nucleus (Figure 1B).
These findings suggest that VDR acts like a lock waiting for its key. Access to the key (vitamin D), and migration of the VDR into the nucleus, possibly unlocks the transcriptional regulation required to modulate the immune pathways. Furthermore, VDR expression was contingent upon baseline vitamin D levels, suggesting that this vitamin has both a preventive and therapeutic potential. Kiliç et al. also found that one of the genes that VDR regulates (called Ikzf3) is a major factor in suppressing the Th2 immune response (Figure 1B). This effect is likely mediated through the STAT signaling axis, which is a critical pathway regulating inflammation (Hu et al., 2021).
The study by Kiliç, Halu, Weiss and colleagues sheds light on how vitamin D offers protective benefits against asthma. However, several pathophysiological pathways can lead to the characteristic airway inflammation associated with asthma (Moore and Bleecker, 2014). Subgroup analysis during clinical trials, along with targeted exploration of relevant biomarkers, could help identify who would benefit most from vitamin D supplements. The latest findings also underscore the importance of vitamin D in a wider sense, as the Th2 response is associated with several other chronic inflammatory diseases.
That being said, it is essential to be mindful of the broader biological role of vitamin D, as it influences both the innate and the adaptive immune system via a number of different cell types (Colotta et al., 2017). This complexity may be why scientific literature on vitamin D is marred by contradictory findings: for instance, a previous study has even shown loss of VDR to be protective against asthma (Wittke et al., 2004). However, this complexity should not deter researchers from trying to develop a deeper mechanistic understanding of vitamin D effects. Such an understanding could, in the future, enable personalized treatment strategies for individuals with immune disorders such as asthma.
References
-
Advances in asthma geneticsAdvances in Genetics 107:1–32.https://doi.org/10.1016/bs.adgen.2020.11.001
-
Modulation of inflammatory and immune responses by vitamin DJournal of Autoimmunity 85:78–97.https://doi.org/10.1016/j.jaut.2017.07.007
-
The JAK/STAT signaling pathway: from bench to clinicSignal Transduction and Targeted Therapy 6:402.https://doi.org/10.1038/s41392-021-00791-1
-
Six-year follow-up of a trial of antenatal vitamin D for asthma reductionThe New England Journal of Medicine 382:525–533.https://doi.org/10.1056/NEJMoa1906137
-
Asthma heterogeneity and severity-why is comprehensive phenotyping important?Lancet Respiratory Medicine 2:10–11.https://doi.org/10.1016/S2213-2600(13)70288-1
-
Limitations of vitamin D supplementation trials: Why observational studies will continue to help determine the role of vitamin D in healthThe Journal of Steroid Biochemistry and Molecular Biology 177:6–9.https://doi.org/10.1016/j.jsbmb.2017.06.006
-
Vitamin D receptor-deficient mice fail to develop experimental allergic asthmaJournal of Immunology 173:3432–3436.https://doi.org/10.4049/jimmunol.173.5.3432
-
Vitamin D supplementation in pregnancy, prenatal 25(OH)D levels, race, and subsequent asthma or recurrent wheeze in offspring: Secondary analyses from the Vitamin D Antenatal Asthma Reduction TrialThe Journal of Allergy and Clinical Immunology 140:1423–1429.https://doi.org/10.1016/j.jaci.2017.01.013
Article and author information
Author details
Publication history
Copyright
© 2024, Sharma and Garg
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 610
- views
-
- 57
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Genetics and Genomics
N6-methyladenosine (m6A) in eukaryotic RNA is an epigenetic modification that is critical for RNA metabolism, gene expression regulation, and the development of organisms. Aberrant expression of m6A components appears in a variety of human diseases. RNA m6A modification in Drosophila has proven to be involved in sex determination regulated by Sxl and may affect X chromosome expression through the MSL complex. The dosage-related effects under the condition of genomic imbalance (i.e. aneuploidy) are related to various epigenetic regulatory mechanisms. Here, we investigated the roles of RNA m6A modification in unbalanced genomes using aneuploid Drosophila. The results showed that the expression of m6A components changed significantly under genomic imbalance, and affected the abundance and genome-wide distribution of m6A, which may be related to the developmental abnormalities of aneuploids. The relationships between methylation status and classical dosage effect, dosage compensation, and inverse dosage effect were also studied. In addition, we demonstrated that RNA m6A methylation may affect dosage-dependent gene regulation through dosage-sensitive modifiers, alternative splicing, the MSL complex, and other processes. More interestingly, there seems to be a close relationship between MSL complex and RNA m6A modification. It is found that ectopically overexpressed MSL complex, especially the levels of H4K16Ac through MOF, could influence the expression levels of m6A modification and genomic imbalance may be involved in this interaction. We found that m6A could affect the levels of H4K16Ac through MOF, a component of the MSL complex, and that genomic imbalance may be involved in this interaction. Altogether, our work reveals the dynamic and regulatory role of RNA m6A modification in unbalanced genomes, and may shed new light on the mechanisms of aneuploidy-related developmental abnormalities and diseases.
-
- Computational and Systems Biology
- Genetics and Genomics
Apart from ancestry, personal or environmental covariates may contribute to differences in polygenic score (PGS) performance. We analyzed the effects of covariate stratification and interaction on body mass index (BMI) PGS (PGSBMI) across four cohorts of European (N = 491,111) and African (N = 21,612) ancestry. Stratifying on binary covariates and quintiles for continuous covariates, 18/62 covariates had significant and replicable R2 differences among strata. Covariates with the largest differences included age, sex, blood lipids, physical activity, and alcohol consumption, with R2 being nearly double between best- and worst-performing quintiles for certain covariates. Twenty-eight covariates had significant PGSBMI–covariate interaction effects, modifying PGSBMI effects by nearly 20% per standard deviation change. We observed overlap between covariates that had significant R2 differences among strata and interaction effects – across all covariates, their main effects on BMI were correlated with their maximum R2 differences and interaction effects (0.56 and 0.58, respectively), suggesting high-PGSBMI individuals have highest R2 and increase in PGS effect. Using quantile regression, we show the effect of PGSBMI increases as BMI itself increases, and that these differences in effects are directly related to differences in R2 when stratifying by different covariates. Given significant and replicable evidence for context-specific PGSBMI performance and effects, we investigated ways to increase model performance taking into account nonlinear effects. Machine learning models (neural networks) increased relative model R2 (mean 23%) across datasets. Finally, creating PGSBMI directly from GxAge genome-wide association studies effects increased relative R2 by 7.8%. These results demonstrate that certain covariates, especially those most associated with BMI, significantly affect both PGSBMI performance and effects across diverse cohorts and ancestries, and we provide avenues to improve model performance that consider these effects.